When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
MYOK - MyoKardia's danicamtiv shows positive action in mid-stage study
MyoKardia Inc.
MyoKardia (MYOK-0.8%) announces positive results from a Phase 2a clinical trial evaluating danicamtiv in stable heart failure patients with reduced ejection fraction. The data were presented virtually at the European Society of Cardiology's Heart Failure Association Discoveries event.
More news on: MyoKardia, Inc., Healthcare stocks news,